Special populations and clinical contexts. The emphasis on tailoring treatment includes a summary of
management in special contexts (surgery, exercise-induced bronchoconstriction); for patients with
comorbidities (e.g. obesity, anxiety, rhinosinusitis); and in special populations (e.g. elderly, aspirin-exacerbated
respiratory disease, pregnancy). Active treatment of asthma in pregnancy, with review every 4–6 weeks, is
strongly recommended, with a new recommendation against down-titration of treatment during the short
duration of pregnancy (except if the ICS dose is very high), because of the high priority placed upon avoiding
any exacerbations in order to reduce risk to the fetus